Compare EPR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPR | HAE |
|---|---|---|
| Founded | 1997 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.9B |
| IPO Year | 1997 | 1991 |
| Metric | EPR | HAE |
|---|---|---|
| Price | $54.97 | $70.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $57.06 | ★ $88.75 |
| AVG Volume (30 Days) | ★ 706.8K | 673.3K |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | ★ 6.45% | N/A |
| EPS Growth | N/A | ★ 42.54 |
| EPS | 2.29 | ★ 3.44 |
| Revenue | $707,150,000.00 | ★ $1,327,850,000.00 |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $2.95 | $6.01 |
| P/E Ratio | $24.01 | ★ $20.38 |
| Revenue Growth | ★ 3.73 | N/A |
| 52 Week Low | $41.75 | $47.32 |
| 52 Week High | $61.24 | $87.32 |
| Indicator | EPR | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 68.03 | 27.72 |
| Support Level | $54.51 | $69.78 |
| Resistance Level | $56.03 | $73.00 |
| Average True Range (ATR) | 1.05 | 2.65 |
| MACD | 0.37 | -1.62 |
| Stochastic Oscillator | 84.21 | 2.39 |
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.